
NBSE
Healthcare · Biotechnology · $1.4M market cap
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2023
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 9, 2023 | After the close | -1.82 | -0.66 | +63.7% |
| Aug 14, 2023 | After the close | -2.00 | -2.04 | -2.0% |
| May 11, 2023 | After the close | -0.11 | -0.12 | -9.1% |
| Feb 14, 2023 | After the close | -0.15 | -0.11 | +26.7% |
| Dec 21, 2022 | After the close | -0.28 | -0.24 | +14.3% |
| Aug 11, 2022 | After the close | -0.30 | -0.26 | +13.3% |
| May 12, 2022 | After the close | -0.23 | -0.30 | -30.4% |
| Feb 11, 2022 | Time not confirmed | -0.23 | -0.24 | -4.3% |
| Dec 23, 2021 | After the close | -0.23 | -0.21 | +8.7% |
| Aug 13, 2021 | After the close | -0.21 | -0.29 | -38.1% |
| May 14, 2021 | Before the open | -0.22 | -0.24 | -9.1% |
| Feb 11, 2021 | After the close | -0.23 | -0.18 | +21.7% |
| Dec 23, 2020 | After the close | -0.20 |
NeuBase Therapeutics, Inc., a preclinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as well as other genetic disorders, and cancer and oncology applications.…
| -0.19 |
| +5.0% |
| Aug 13, 2020 | After the close | -0.23 | -0.18 | +21.7% |
| May 14, 2020 | After the close | -0.22 | -0.26 | -18.2% |
| Mar 26, 2020 | After the close | -0.32 | -0.26 | +18.8% |
| Aug 14, 2019 | After the close | — | -0.40 | — |
| May 15, 2019 | After the close | — | -0.40 | — |
| Feb 14, 2019 | After the close | -0.07 | -0.32 | -357.1% |
| Dec 15, 2018 | Time not confirmed | -0.26 | -0.11 | +57.7% |
| Aug 14, 2018 | After the close | -0.11 | -0.01 | +90.9% |
| May 15, 2018 | After the close | -1.40 | -1.00 | +28.6% |
| Feb 14, 2018 | After the close | -1.40 | -1.40 | 0.0% |